Virus News and Research

Latest Virus News and Research

Inviragen commences DENVax Phase 2 trial for dengue

Inviragen, Inc. today announced the initiation of a Phase 2, randomized, double-blind, placebo-controlled study of DENVax, the Company's investigational dengue vaccine.

28 Nov 2011

Suppressing mosquitoes - the only way of controlling dengue

There is no vaccine against dengue, an emerging tropical disease regularly also hitting tourists, so the only way of controlling it is by suppressing the mosquitoes transmitting the disease.

28 Nov 2011

Mass immunization with cervical cancer vaccine switched to a more effective variety

Cervarix is currently offered to girls aged 12 and 13 years to protect against strains of the sexually transmitted human papillomavirus (HPV), which causes most cases of cancer of the cervix, the neck of the womb. Cervarix was picked by the Labour government for the first four-year phase of the NHS programme in 2008 because it offered ‘best overall value’ and more than five million doses have been given.

27 Nov 2011

IPS reports on child poverty in Lesotho

"The triple threat of HIV, poverty and food insecurity is increasingly exposing children to abuse, exploitation and other human rights violations" in Lesotho, Inter Press Service reports in an article examining child poverty in the small southern African country.

24 Nov 2011

NIH-led study advances HIV vaccine research

HIV is coated in sugars that usually hide the virus from the immune system. Newly published research reveals how one broadly neutralizing HIV antibody actually uses part of the sugary cloak to help bind to the virus. The antibody binding site, called the V1/V2 region, represents a suitable HIV vaccine target, according to the scientists who conducted the study. In addition, their research reveals the detailed structure of the V1/V2 region, the last part of the virus surface to be visualized at the atomic level.

24 Nov 2011

University of Rochester receives U.S. patent for HPV vaccine research

The University of Rochester has been awarded a U.S. patent for research essential to both human papillomavirus vaccines on the market.

23 Nov 2011

George W. Bush to travel to Africa to raise awareness about cervical, breast cancer

Former President George W. Bush will travel next month with former first lady Laura Bush and officials with the George W. Bush Institute to Tanzania, Zambia and Ethiopia "where they'll visit clinics and meet with governmental and health care leaders ... to raise awareness about cervical and breast cancer, an effort he calls a 'natural extension' of" the PEPFAR program launched during his presidency, the Associated Press reports.

23 Nov 2011

University of Liverpool introduces HEP i-chart for HCV patients

The University of Liverpool has launched an iphone app, HEP i-chart, that provides Hepatitis C (HCV) patients with quick and easy access to the latest information about drug interactions.

23 Nov 2011

IPS examines HIV in the Caribbean, highlights challenges in addressing at-risk populations

Inter Press Service examines HIV in the Caribbean, where "the HIV burden varies considerably among and within countries" in the region. "'I think the prevention programs in many countries are not reaching the right people,' Michel de Groulards, regional program adviser of the UNAIDS Caribbean Regional Support Team, told IPS," the news service writes, adding, "One factor, de Groulards believed, may be that after 25 years of providing treatment, some countries have reached a plateau.

23 Nov 2011

FSU professors available to provide perspective on fight against HIV/AIDS

As the world prepares to mark World AIDS Day on Dec. 1, two Florida State University professors are available to provide perspective on the fight against HIV/AIDS.

22 Nov 2011

Fight against HIV/AIDS continues with successes and failures: UNAIDS report

An annual report released Monday by UNAIDS, the United Nations agency fighting AIDS has revealed that the world’s AIDS epidemic has hit a plateau, with 2.7 million people becoming newly infected each year for the last five years.

22 Nov 2011

Scientists identify new immune system defect in aged mice

As people age, their immune system becomes less robust. This makes them more susceptible to serious and frequently life-threatening infections with viruses that affect the respiratory tract such as influenza A virus.

22 Nov 2011

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

A novel antibacterial protein targeted against E. coli O157:H7 may offer a way to prevent or treat serious food-borne bacterial infections, as demonstrated in a study published in the December issue of Antimicrobial Agents and Chemotherapy.

21 Nov 2011

Gilead enters agreement for Pharmasset acquisition

Gilead Sciences, Inc. and Pharmasset, Inc. announced today that the companies have signed a definitive agreement under which Gilead will acquire Pharmasset for $137 per share in cash.

21 Nov 2011

Positive preliminary results from Alnylam's ALN-TTR01 Phase I clinical trial for TTR-mediated amyloidosis

Alnylam Pharmaceuticals, Inc., a leading RNAi therapeutics company, announced today positive preliminary results from its Phase I clinical trial with ALN-TTR01, an RNAi therapeutic targeting transthyretin (TTR) for the treatment of TTR-mediated amyloidosis (ATTR).

21 Nov 2011

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Adeona Pharmaceuticals, Inc., and the Human Therapeutics Division of Intrexon Corporation, announced today the formation of a global exclusive channel collaboration through which Adeona intends to develop and commercialize a DNA-based therapeutic using Intrexon's UltraVector platform and RheoSwitch Therapeutic System for the treatment of pulmonary arterial hypertension (PAH).

21 Nov 2011

Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea

21 Nov 2011

Scientists isolate and analyze antibody that neutralizes Sudan virus

Scientists from The Scripps Research Institute and the US Army's Medical Research Institute of Infectious Diseases have isolated and analyzed an antibody that neutralizes Sudan virus, a major species of ebolavirus and one of the most dangerous human pathogens.

20 Nov 2011

PEPFAR Scientific Advisory Board report offers six recommended research priorities

This post in the Center for Global Health Policy's "Science Speaks" blog examines a report by the PEPFAR Scientific Advisory Board (SAB) that offers six recommended treatment and prevention research priorities to U.S. Global AIDS Ambassador Eric Goosby and the Office of the Global AIDS Coordinator (OGAC) to guide future PEPFAR programs.

19 Nov 2011

GAVI Alliance to fund roll-out of vaccines against cervical cancer, rubella in developing countries

The GAVI Alliance "has agreed to fund the roll-out of vaccines against cervical cancer in developing countries, offering protection against a disease that kills one woman every two minutes," Reuters reports.

19 Nov 2011

Virus News and Research

Latest Virus News and Research

Inviragen commences DENVax Phase 2 trial for dengue

Suppressing mosquitoes - the only way of controlling dengue

Mass immunization with cervical cancer vaccine switched to a more effective variety

IPS reports on child poverty in Lesotho

NIH-led study advances HIV vaccine research

University of Rochester receives U.S. patent for HPV vaccine research

George W. Bush to travel to Africa to raise awareness about cervical, breast cancer

University of Liverpool introduces HEP i-chart for HCV patients

IPS examines HIV in the Caribbean, highlights challenges in addressing at-risk populations

FSU professors available to provide perspective on fight against HIV/AIDS

Fight against HIV/AIDS continues with successes and failures: UNAIDS report

Scientists identify new immune system defect in aged mice

Novel antibacterial protein could prevent or treat E. coli O157:H7-induced food-borne infections

Gilead enters agreement for Pharmasset acquisition

Positive preliminary results from Alnylam's ALN-TTR01 Phase I clinical trial for TTR-mediated amyloidosis

Adeona to develop and commercialize DNA-based therapeutic for PAH using Intrexon technology

Avidocin protein could prevent or treat E. coli O157:H7-induced diarrhea

Scientists isolate and analyze antibody that neutralizes Sudan virus

PEPFAR Scientific Advisory Board report offers six recommended research priorities

GAVI Alliance to fund roll-out of vaccines against cervical cancer, rubella in developing countries

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Virus News and Research

Latest Virus News and Research

Achieving and maintaining ISO/IEC 27001 and BS 10012 certifications

Expanding research and clinical options for children with cancer

Examining how pain could play a direct protective role in the gut

Newsletters you may be interested in